U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889388) titled 'RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study' on Oct. 16.
Brief Summary: This study will evaluate the accuracy and safety of the RIGHTEST iFree 2 Continuous Glucose Monitoring (CGM) System in pregnant women with type 1 diabetes, type 2 diabetes, or gestational diabetes. The system uses a small sensor placed under the skin to measure glucose levels in the fluid between cells.
Approximately 104 women will participate at study sites in Germany and Taiwan. Each participant will wear two sensors, one on each upper arm, for up to 15 days. During one clinic visit lasting up to six hours, blood samples will be collected every...